COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study

Background: Although periconception vaccination is important for maternal and neonatal health, vaccine hesitancy could pose a challenge to achieving a healthy pregnancy in infertile women. We assessed the prevalence of coronavirus disease 2019 (COVID-19) booster vaccination, associated factors, adve...

Full description

Bibliographic Details
Main Authors: Seul Gee Park, Eunsun Kwak, Taemi Kim, Young June Choe, Seung-Ah Choe, Jee Hyun Kim
Format: Article
Language:English
Published: IMR Press 2023-12-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/50/12/10.31083/j.ceog5012267
_version_ 1797365394655150080
author Seul Gee Park
Eunsun Kwak
Taemi Kim
Young June Choe
Seung-Ah Choe
Jee Hyun Kim
author_facet Seul Gee Park
Eunsun Kwak
Taemi Kim
Young June Choe
Seung-Ah Choe
Jee Hyun Kim
author_sort Seul Gee Park
collection DOAJ
description Background: Although periconception vaccination is important for maternal and neonatal health, vaccine hesitancy could pose a challenge to achieving a healthy pregnancy in infertile women. We assessed the prevalence of coronavirus disease 2019 (COVID-19) booster vaccination, associated factors, adverse event after vaccination, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among women seeking fertility treatment. Methods: We used the data from participants of the Pregnancy and Urban Environment study (PRUNE study), which is a prospective observational study designed to explore the association between pregnancy and the urban environment in infertile couples. From October 2019 to September 2021, a total of 534 patients provided informed consent and participated in the first and second rounds of a mobile survey conducted at six-month intervals. In the second and third rounds of the survey, we included questions about COVID-19 vaccination and SARS-CoV-2 infection. Adjusted risk ratios (aRR) were calculated for COVID-19 booster vaccination and SARS-CoV-2 infection. Results: All the women participating in the survey had completed the primary series of COVID-19 vaccination. The booster vaccination rate was 38.5%, and the prevalence of SARS-CoV-2 infection was 34.4%. The likelihood of receiving a booster vaccination was higher when women reported alcohol consumption (aRR = 1.90, 95% confidence interval (CI): 1.03–3.51, p = 0.041). SARS-CoV-2 infection was inversely associated with nulliparity (aRR = 0.44, 95% CI: 0.17–1.09, p = 0.077). Among the women vaccinated against COVID-19, 44.3% of respondents reported at least one adverse reaction after receiving the vaccine. Conclusions: All the women participating in the survey had completed primary series of COVID-19 vaccination. The booster vaccination rate was 38.5%, and the prevalence of SARS-CoV-2 infection was 34.4%. Among the vaccinated women, 44.3% reported experiencing at least one adverse reaction after receiving the COVID-19 vaccine. Fever/chilling was the most common (61.8%), followed by abnormal vaginal bleeding/menstrual irregularity (41.8%). A targeted education program by health professionals is needed to promote the benefits of periconception vaccination and reduce the resistance to the COVID-19 vaccine among infertile couples. Clinical Trial Registration: The study was registered at Clinical Research Information Service (https://cris.nih.go.kr/cris/info/dataset.do), registration number: KCT0003560.
first_indexed 2024-03-08T16:48:15Z
format Article
id doaj.art-ad62518d6c0844939f9ddd86c415078c
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-03-08T16:48:15Z
publishDate 2023-12-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-ad62518d6c0844939f9ddd86c415078c2024-01-05T07:27:09ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632023-12-01501226710.31083/j.ceog5012267S0390-6663(23)02222-4COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective StudySeul Gee Park0Eunsun Kwak1Taemi Kim2Young June Choe3Seung-Ah Choe4Jee Hyun Kim5CHA Fertility Center Bundang, CHA University, 13488 Gyeonggi-Do, Republic of KoreaDepartment of Preventive Medicine, Korea University College of Medicine, 13520 Seoul, Republic of KoreaDepartment of Public Health Science, Korea University, 13520 Seoul, Republic of KoreaDepartment of Pediatrics, Korea University Anam Hospital, 13520 Seoul, Republic of KoreaDepartment of Preventive Medicine, Korea University College of Medicine, 13520 Seoul, Republic of KoreaCHA Fertility Center Bundang, CHA University, 13488 Gyeonggi-Do, Republic of KoreaBackground: Although periconception vaccination is important for maternal and neonatal health, vaccine hesitancy could pose a challenge to achieving a healthy pregnancy in infertile women. We assessed the prevalence of coronavirus disease 2019 (COVID-19) booster vaccination, associated factors, adverse event after vaccination, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among women seeking fertility treatment. Methods: We used the data from participants of the Pregnancy and Urban Environment study (PRUNE study), which is a prospective observational study designed to explore the association between pregnancy and the urban environment in infertile couples. From October 2019 to September 2021, a total of 534 patients provided informed consent and participated in the first and second rounds of a mobile survey conducted at six-month intervals. In the second and third rounds of the survey, we included questions about COVID-19 vaccination and SARS-CoV-2 infection. Adjusted risk ratios (aRR) were calculated for COVID-19 booster vaccination and SARS-CoV-2 infection. Results: All the women participating in the survey had completed the primary series of COVID-19 vaccination. The booster vaccination rate was 38.5%, and the prevalence of SARS-CoV-2 infection was 34.4%. The likelihood of receiving a booster vaccination was higher when women reported alcohol consumption (aRR = 1.90, 95% confidence interval (CI): 1.03–3.51, p = 0.041). SARS-CoV-2 infection was inversely associated with nulliparity (aRR = 0.44, 95% CI: 0.17–1.09, p = 0.077). Among the women vaccinated against COVID-19, 44.3% of respondents reported at least one adverse reaction after receiving the vaccine. Conclusions: All the women participating in the survey had completed primary series of COVID-19 vaccination. The booster vaccination rate was 38.5%, and the prevalence of SARS-CoV-2 infection was 34.4%. Among the vaccinated women, 44.3% reported experiencing at least one adverse reaction after receiving the COVID-19 vaccine. Fever/chilling was the most common (61.8%), followed by abnormal vaginal bleeding/menstrual irregularity (41.8%). A targeted education program by health professionals is needed to promote the benefits of periconception vaccination and reduce the resistance to the COVID-19 vaccine among infertile couples. Clinical Trial Registration: The study was registered at Clinical Research Information Service (https://cris.nih.go.kr/cris/info/dataset.do), registration number: KCT0003560.https://www.imrpress.com/journal/CEOG/50/12/10.31083/j.ceog5012267covid-19booster vaccinationinfertilityvaccine hesitancyadverse effectsars-cov-2
spellingShingle Seul Gee Park
Eunsun Kwak
Taemi Kim
Young June Choe
Seung-Ah Choe
Jee Hyun Kim
COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
Clinical and Experimental Obstetrics & Gynecology
covid-19
booster vaccination
infertility
vaccine hesitancy
adverse effect
sars-cov-2
title COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
title_full COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
title_fullStr COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
title_full_unstemmed COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
title_short COVID-19 Vaccination, Adverse Effect, and SARS-CoV-2 Infection among Couples in Infertility Clinic: A Prospective Study
title_sort covid 19 vaccination adverse effect and sars cov 2 infection among couples in infertility clinic a prospective study
topic covid-19
booster vaccination
infertility
vaccine hesitancy
adverse effect
sars-cov-2
url https://www.imrpress.com/journal/CEOG/50/12/10.31083/j.ceog5012267
work_keys_str_mv AT seulgeepark covid19vaccinationadverseeffectandsarscov2infectionamongcouplesininfertilityclinicaprospectivestudy
AT eunsunkwak covid19vaccinationadverseeffectandsarscov2infectionamongcouplesininfertilityclinicaprospectivestudy
AT taemikim covid19vaccinationadverseeffectandsarscov2infectionamongcouplesininfertilityclinicaprospectivestudy
AT youngjunechoe covid19vaccinationadverseeffectandsarscov2infectionamongcouplesininfertilityclinicaprospectivestudy
AT seungahchoe covid19vaccinationadverseeffectandsarscov2infectionamongcouplesininfertilityclinicaprospectivestudy
AT jeehyunkim covid19vaccinationadverseeffectandsarscov2infectionamongcouplesininfertilityclinicaprospectivestudy